Cargando…
Thiamine Deficiency and Neurological Symptoms in Patients with Hematological Cancer Receiving Chemotherapy: A Retrospective Analysis
Objectives Patients with hematological cancer receiving chemotherapy have a high risk of thiamine deficiency due to accelerated thiamine usage by tumor cells. Mild or severe thiamine deficiency can lead to varying degrees of neurological symptoms. We evaluated the relationship between thiamine defi...
Autores principales: | Iimura, Yohei, Andoh, Shohei, Kawamata, Toyotaka, Sato, Aki, Yokoyama, Kazuaki, Imai, Yoichi, Tojo, Arinobu, Nojima, Masanori, Sugiura, Munetoshi, Kuroda, Seiichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559079/ https://www.ncbi.nlm.nih.gov/pubmed/34737507 http://dx.doi.org/10.1055/s-0041-1735825 |
Ejemplares similares
-
Role of Circulating Tumor DNA in Hematological Malignancy
por: Ogawa, Miho, et al.
Publicado: (2021) -
Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient
por: Takeda, Reina, et al.
Publicado: (2020) -
CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia
por: Kaito, Yuta, et al.
Publicado: (2022) -
An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review
por: Takeda, Reina, et al.
Publicado: (2019) -
CD4(+)CADM1(+) cell percentage predicts disease progression in HTLV‐1 carriers and indolent adult T‐cell leukemia/lymphoma
por: Makiyama, Junya, et al.
Publicado: (2019)